Abstract
The effects of a known antipsychotic agent (haloperidol) were assessed using both a behavioral model and a prolactin (PRL) model for screening potential antipsychotic drugs in the rat. The PRL model was found to be highly reliable and more sensitive than the behavioral model.
References
Clemens J, Smalstig E, Sawyer B (1974) Antipsychotic drugs stimulate prolactin release. Psychopharmacology 40:123–127
Horn A, Snyder SH (1974) Chlorpromazine and dopamine: Conformational similarities that correlate with the antischizophrenic activity of phenothiazine drugs. Proc Natl Acad Sci USA 68:2325–2328
Matthysse S (1974) Dopamine and the pharmacology of schizophrenia: The state of the evidence. J Psychiatr Res 11:107–113
Mueller G, Simpkins J, Meites J, Moore KE (1976) Differential effects of dopamine agonists and haloperidol on the release of prolactin, thyroid-stimulating hormone, growth hormone, and luteinizing hormone in rats. Neuroendocrinology 20:121–135
Sachar E, Gruen P, Altman N (1977) The use of the prolactin response in clinical psychopharmacology. Psychopharmacol Bull 13:60–61
Sayers A, Burki H, Ruch W, Asper H (1976) Anticholinergic properties of antipsychotic drugs and their relation to extrapyramidal side effects. Psychopharmacology 51:15–22
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Feigenbaum, J.J., Moon, B.H., Catterton, R. et al. Haloperidol-induced plasma prolactin release: Sensitivity, reliability, and comparison to haloperidol antagonism of dopamine agonist-induced stereotyped behavior in the rat. Psychopharmacology 78, 383–384 (1982). https://doi.org/10.1007/BF00433748
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00433748